United Statesbiobridgeglobal.org/bbg-advanced-therapies
BBG Advanced Therapies (BBGAT) is a U.S.-based contract development and manufacturing organization and a subsidiary of BioBridge Global. The company focuses on advanced therapy medicinal products, supporting the development and manufacture of cell- and gene-based therapies for biotechnology and biopharmaceutical clients.
BBG Advanced Therapies provides integrated services spanning donor material sourcing and cell collection, process and analytical development, cGMP clinical manufacturing, quality control, cryopreservation, and controlled logistics. Its quality and regulatory frameworks are designed to help programs progress from early development through scale-up toward commercialization, enabling reliable, compliant production of advanced therapies.
None yet. When a new project in the record names BBGAT as owner, partner or investor, it shows here.
The partnership enhances global CDMO capacity, offering integrated services for ATMP development and manufacturing, leveraging expertise and infrastructure across the U.S. and Europe.
